| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | neuron projection retraction | 3.51e-06 | 4 | 199 | 3 | GO:0106028 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | LIPG PI4KA CDIPT PLCB1 PLCB3 PLCB4 SMPD3 FAR1 NR1H4 HDHD5 PIGS SLC44A4 ETNK2 BSCL2 IPMK | 1.13e-05 | 410 | 199 | 15 | GO:0006644 |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | PI4KA CDIPT PLCB1 PLCB3 PLCB4 FAR1 NR1H4 HDHD5 PIGS SLC44A4 ETNK2 BSCL2 IPMK | 1.48e-05 | 320 | 199 | 13 | GO:0006650 |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | CLCN2 ST3GAL5 LIPG PI4KA CDIPT ABCD3 HSD3B1 ABCD1 SMPD3 FAR1 ALOX12B NR1H4 ABCC1 HDHD5 PIGS ST3GAL3 LBR SLC44A4 ETNK2 ST6GALNAC4 BSCL2 | 4.14e-05 | 813 | 199 | 21 | GO:0008610 |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 5.37e-05 | 22 | 199 | 4 | GO:1902001 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | LIPG PI4KA CDIPT PLCB1 PLCB3 PLCB4 FAR1 NR1H4 HDHD5 PIGS SLC44A4 ETNK2 BSCL2 IPMK | 7.68e-05 | 429 | 199 | 14 | GO:0046486 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 7.68e-05 | 24 | 199 | 4 | GO:0048015 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidic acid biosynthetic process | 9.26e-05 | 2 | 199 | 2 | GO:1905693 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | ADCY10 EOGT PDK1 PDK3 RRM1 JAK3 CHST15 ST3GAL5 PLCB1 SMPD3 UAP1L1 CHST3 NDUFB11 PIGS POMGNT1 ST3GAL3 NDUFA13 CHSY3 ST6GALNAC4 | 9.84e-05 | 736 | 199 | 19 | GO:1901137 |
| Domain | PLC-beta_CS | 1.16e-06 | 3 | 197 | 3 | IPR009535 | |
| Domain | DUF1154 | 1.16e-06 | 3 | 197 | 3 | PF06631 | |
| Domain | PH_dom-like | ARHGAP24 MYO7B KIF1B PLEKHH1 JAK3 PLCB1 PHLPP1 TLN2 PLCB3 PLCB4 ARHGEF6 DOCK10 CNKSR2 PLEKHA6 OPHN1 FRMPD3 SOS2 | 2.92e-06 | 426 | 197 | 17 | IPR011993 |
| Domain | PLC-beta | 4.59e-06 | 4 | 197 | 3 | IPR016280 | |
| Domain | DUF3398 | 2.26e-05 | 6 | 197 | 3 | PF11878 | |
| Domain | DOCK_C/D_N | 2.26e-05 | 6 | 197 | 3 | IPR021816 | |
| Domain | - | ARHGAP24 MYO7B KIF1B PLEKHH1 PHLPP1 TLN2 PLCB3 PLCB4 ARHGEF6 DOCK10 CNKSR2 PLEKHA6 OPHN1 SOS2 | 7.29e-05 | 391 | 197 | 14 | 2.30.29.30 |
| Domain | FA_transporter | 1.11e-04 | 2 | 197 | 2 | IPR005283 | |
| Domain | AAA | 1.47e-04 | 144 | 197 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 1.47e-04 | 144 | 197 | 8 | IPR003593 | |
| Domain | FERM_domain | 1.62e-04 | 49 | 197 | 5 | IPR000299 | |
| Domain | PH | ARHGAP24 KIF1B PLEKHH1 PHLPP1 ARHGEF6 DOCK10 CNKSR2 PLEKHA6 OPHN1 SOS2 | 1.65e-04 | 229 | 197 | 10 | PF00169 |
| Domain | FERM_1 | 1.79e-04 | 50 | 197 | 5 | PS00660 | |
| Domain | FERM_2 | 1.79e-04 | 50 | 197 | 5 | PS00661 | |
| Domain | FERM_3 | 1.79e-04 | 50 | 197 | 5 | PS50057 | |
| Domain | Band_41_domain | 1.79e-04 | 50 | 197 | 5 | IPR019749 | |
| Domain | B41 | 1.79e-04 | 50 | 197 | 5 | SM00295 | |
| Domain | DHR-1_domain | 1.79e-04 | 11 | 197 | 3 | IPR027007 | |
| Domain | DHR_2 | 1.79e-04 | 11 | 197 | 3 | PS51651 | |
| Domain | DHR_1 | 1.79e-04 | 11 | 197 | 3 | PS51650 | |
| Domain | DHR-2 | 1.79e-04 | 11 | 197 | 3 | PF06920 | |
| Domain | DOCK | 1.79e-04 | 11 | 197 | 3 | IPR026791 | |
| Domain | DOCK_C | 1.79e-04 | 11 | 197 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 1.79e-04 | 11 | 197 | 3 | PF14429 | |
| Domain | DHR-2 | 1.79e-04 | 11 | 197 | 3 | IPR027357 | |
| Domain | PLC-beta_C | 3.30e-04 | 3 | 197 | 2 | PF08703 | |
| Domain | PLC-beta_C | 3.30e-04 | 3 | 197 | 2 | IPR014815 | |
| Domain | EF-hand_like | 4.79e-04 | 15 | 197 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 4.79e-04 | 15 | 197 | 3 | PF00387 | |
| Domain | PLCYc | 4.79e-04 | 15 | 197 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 4.79e-04 | 15 | 197 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 4.79e-04 | 15 | 197 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 4.79e-04 | 15 | 197 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 4.79e-04 | 15 | 197 | 3 | IPR015359 | |
| Domain | ABC_membrane_2 | 6.55e-04 | 4 | 197 | 2 | PF06472 | |
| Domain | P-loop_NTPase | ADCY10 MYO7B KIF1B NWD2 ATAD3C CHST15 ABCD3 ABCD1 ASCC3 CHST3 DNHD1 ABCC1 DNAH3 MYH7B RNF213 RHOQ PALS1 UTP25 CHTF18 HYDIN | 6.63e-04 | 848 | 197 | 20 | IPR027417 |
| Domain | PH | ARHGAP24 KIF1B PLEKHH1 PHLPP1 ARHGEF6 DOCK10 CNKSR2 PLEKHA6 OPHN1 SOS2 | 7.62e-04 | 278 | 197 | 10 | SM00233 |
| Domain | PH_DOMAIN | ARHGAP24 KIF1B PLEKHH1 PHLPP1 ARHGEF6 DOCK10 CNKSR2 PLEKHA6 OPHN1 SOS2 | 7.83e-04 | 279 | 197 | 10 | PS50003 |
| Domain | PH_domain | ARHGAP24 KIF1B PLEKHH1 PHLPP1 ARHGEF6 DOCK10 CNKSR2 PLEKHA6 OPHN1 SOS2 | 8.05e-04 | 280 | 197 | 10 | IPR001849 |
| Domain | PI-PLC-X | 8.39e-04 | 18 | 197 | 3 | PF00388 | |
| Domain | PLCXc | 8.39e-04 | 18 | 197 | 3 | SM00148 | |
| Domain | - | ADCY10 MYO7B NWD2 ATAD3C CHST15 ABCD3 ABCD1 ASCC3 CHST3 DNHD1 ABCC1 DNAH3 RNF213 RHOQ PALS1 UTP25 CHTF18 HYDIN | 9.56e-04 | 746 | 197 | 18 | 3.40.50.300 |
| Domain | PIPLC_X_DOMAIN | 9.89e-04 | 19 | 197 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 9.89e-04 | 19 | 197 | 3 | IPR000909 | |
| Domain | BCDHK_Adom3 | 1.08e-03 | 5 | 197 | 2 | PF10436 | |
| Domain | His_kinase_dom | 1.08e-03 | 5 | 197 | 2 | IPR005467 | |
| Domain | HIS_KIN | 1.08e-03 | 5 | 197 | 2 | PS50109 | |
| Domain | BCDHK/PDK_N | 1.08e-03 | 5 | 197 | 2 | IPR018955 | |
| Domain | - | 1.08e-03 | 5 | 197 | 2 | 1.20.140.20 | |
| Domain | Glyco_trans_29 | 1.15e-03 | 20 | 197 | 3 | IPR001675 | |
| Domain | Glyco_transf_29 | 1.15e-03 | 20 | 197 | 3 | PF00777 | |
| Domain | FERM_M | 1.39e-03 | 46 | 197 | 4 | PF00373 | |
| Domain | FERM_central | 1.76e-03 | 49 | 197 | 4 | IPR019748 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 1.79e-06 | 54 | 153 | 7 | M3896 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 2.66e-06 | 10 | 153 | 4 | M47644 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 3.20e-06 | 22 | 153 | 5 | M39795 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 3.60e-06 | 39 | 153 | 6 | M39905 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.15e-06 | 11 | 153 | 4 | M49033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 4.15e-06 | 11 | 153 | 4 | M47637 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 6.17e-06 | 12 | 153 | 4 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 6.17e-06 | 12 | 153 | 4 | M47628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.84e-06 | 13 | 153 | 4 | M47656 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP24 NCKAP1 DOCK6 ARHGEF6 DOCK10 LBR OPHN1 NISCH DOCK7 SOS2 | 2.09e-05 | 175 | 153 | 10 | MM15599 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.45e-05 | 6 | 153 | 3 | M47548 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 NCKAP1 NIPSNAP2 POTEE ABCD3 DIAPH2 DOCK6 ARHGEF6 DOCK10 CCDC187 LBR OPHN1 RHOQ NISCH DOCK7 SOS2 | 3.08e-05 | 450 | 153 | 16 | M27078 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP24 NCKAP1 DOCK6 ARHGEF6 DOCK10 LBR OPHN1 NISCH DOCK7 SOS2 | 3.22e-05 | 184 | 153 | 10 | M41809 |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 4.25e-05 | 7 | 153 | 3 | M47505 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 4.55e-05 | 19 | 153 | 4 | M47596 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 6.91e-05 | 21 | 153 | 4 | M47638 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 7.19e-05 | 94 | 153 | 7 | MM15598 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | ACAD11 ST3GAL5 PI4KA CDIPT HSD3B1 ABCD1 SMPD3 FAR1 ALOX12B NR1H4 ABCC1 ST3GAL3 PLEKHA6 LBR CPT1B SLC44A4 ETNK2 SLC22A5 | 1.35e-04 | 620 | 153 | 18 | MM15193 |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 1.35e-04 | 46 | 153 | 5 | M48317 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.42e-04 | 10 | 153 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 1.66e-04 | 26 | 153 | 4 | M47557 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.66e-04 | 48 | 153 | 5 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.66e-04 | 48 | 153 | 5 | MM14589 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.73e-04 | 76 | 153 | 6 | M9052 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 2.23e-04 | 28 | 153 | 4 | M252 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 2.93e-04 | 30 | 153 | 4 | M42578 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 NCKAP1 NIPSNAP2 ABCD3 DIAPH2 DOCK6 ARHGEF6 DOCK10 LBR OPHN1 RHOQ NISCH DOCK7 SOS2 | 3.04e-04 | 439 | 153 | 14 | MM15595 |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 3.34e-04 | 31 | 153 | 4 | M47554 | |
| Pathway | KEGG_GAP_JUNCTION | 4.36e-04 | 90 | 153 | 6 | M4013 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 4.44e-04 | 126 | 153 | 7 | M695 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 4.80e-04 | 34 | 153 | 4 | M210 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | ACAD11 ST3GAL5 PI4KA CDIPT HSD3B1 ABCD1 SMPD3 FAR1 ALOX12B NR1H4 ABCC1 ST3GAL3 PLEKHA6 LBR CPT1B SLC44A4 ARSH ETNK2 SLC22A5 | 5.51e-04 | 757 | 153 | 19 | M27451 |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 8.17e-04 | 39 | 153 | 4 | MM14496 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.08e-04 | 18 | 153 | 3 | M47659 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.68e-04 | 70 | 153 | 5 | M3115 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 1.07e-03 | 19 | 153 | 3 | MM14800 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.07e-03 | 19 | 153 | 3 | M47543 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | ADCY10 KMT2C ABCD3 TLN2 FAR1 DNHD1 MYH7B DOCK10 RNF213 DOCK7 RPA1 PHTF1 | 4.12e-09 | 208 | 203 | 12 | 33230847 |
| Pubmed | ZHX3 SETD1B NCKAP1 KIF1B TSC1 PLEKHH1 CHST15 PLXNB3 BICD2 ZSWIM5 STXBP5 DOCK10 CNKSR2 NISCH DOCK7 | 2.05e-08 | 407 | 203 | 15 | 12693553 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDK1 PDK3 USP11 NIPSNAP2 TSC1 POTEE NSA2 PI4KA CDIPT ABCD3 TRMT61B USP47 NDUFB11 UBQLN2 SRSF4 RPAP3 HDHD5 RNF213 LBR MRPS10 NDUFA13 SNIP1 GET4 NISCH NAT10 RBM7 COX7A2L RPA1 | 5.72e-08 | 1496 | 203 | 28 | 32877691 |
| Pubmed | NCKAP1 PDK1 KIF1B NIPSNAP2 TSC1 NWD2 ATAD3C CLCN6 PI4KA CDIPT GLUD2 ABCD3 TLN2 NDUFB11 VWF CARMIL2 ANK3 CNKSR2 GRIN2B PLEKHA6 OPHN1 NDUFA13 NISCH DOCK7 PLXNA4 PRKCG | 3.15e-07 | 1431 | 203 | 26 | 37142655 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CTTNBP2NL POTEE KMT2C FBXO10 PI4KA CDIPT ABCD3 PLCB3 PLXNB3 DNAH3 MXRA5 RNF213 CPT1B ECPAS KCNG4 PLXNA4 KDM8 RPA1 | 3.80e-07 | 736 | 203 | 18 | 29676528 |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 9753089 | ||
| Pubmed | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. | 7.80e-07 | 4 | 203 | 3 | 9305844 | |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 15174099 | ||
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 7.80e-07 | 4 | 203 | 3 | 31268747 | |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 23006664 | ||
| Pubmed | USP11 RTL3 GLUD2 DIAPH2 ABCD1 ARHGEF6 INTS6L NDUFB11 UBQLN2 CAPN6 CNKSR2 OPHN1 FRMPD3 | 9.27e-07 | 407 | 203 | 13 | 15772651 | |
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 8739298 | ||
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 2841328 | ||
| Pubmed | ARHGAP24 UBAP2 NCKAP1 TBC1D7 TSC1 PI4KA DIAPH2 PLCB1 TLN2 ANK3 CNKSR2 GRIN2B PALS1 NISCH NAT10 DOCK7 PRKCG FRMPD3 RPA1 | 4.26e-06 | 963 | 203 | 19 | 28671696 | |
| Pubmed | PDK1 NIPSNAP2 CFAP54 ATAD3C GLUD2 NDUFB11 ANK3 MYH7B LBR CPT1B NDUFA13 | 4.46e-06 | 331 | 203 | 11 | 29199018 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1B NCKAP1 USP11 PSMB2 TSC1 RRM1 GTF3C5 NSA2 PI4KA ABCD3 ASCC3 FAR1 ALOX12B SRSF6 RPAP3 DOCK10 LBR POLR3B CHTF18 NAT10 RBM7 IK RPA1 | 4.81e-06 | 1353 | 203 | 23 | 29467282 |
| Pubmed | Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice. | 6.74e-06 | 7 | 203 | 3 | 10609087 | |
| Pubmed | 7.70e-06 | 225 | 203 | 9 | 12168954 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ZHX3 NCKAP1 TSC1 KMT2C DIAPH2 PLCB4 ASCC3 ANK3 CCDC187 SPG11 ECPAS IK HYDIN | 8.16e-06 | 497 | 203 | 13 | 36774506 |
| Pubmed | 1.09e-05 | 24 | 203 | 4 | 10843712 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBC1D9B NCKAP1 PSMB2 PI4KA CDIPT ABCD3 ABCD1 ASCC3 FAR1 ABCC1 UBQLN2 PIGS LEMD2 LBR ECPAS NDUFA13 GET4 NISCH | 1.18e-05 | 942 | 203 | 18 | 31073040 |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | PDK1 PDK3 KIF1B NIPSNAP2 DUS2 ATAD3C ACAD11 GLUD2 AGXT ABCD3 HSD3B1 ABCD1 NDUFB11 SLC25A41 HDHD5 CPT1B MRPS10 NDUFA13 COX7A2L | 1.38e-05 | 1047 | 203 | 19 | 18614015 |
| Pubmed | 1.60e-05 | 9 | 203 | 3 | 7589147 | ||
| Pubmed | 1.60e-05 | 9 | 203 | 3 | 10501179 | ||
| Pubmed | 1.78e-05 | 27 | 203 | 4 | 20336759 | ||
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 2.28e-05 | 10 | 203 | 3 | 2033248 | |
| Pubmed | 2.28e-05 | 10 | 203 | 3 | 23295235 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 CFH EOGT GALNS RRM1 CDIPT CHST3 HSPG2 NDUFB11 ABCC1 P3H3 PIGS LEMD2 RNF149 POMGNT1 RNF213 LBR CHSY3 ST6GALNAC4 BSCL2 | 2.77e-05 | 1201 | 203 | 20 | 35696571 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D9B ZNF585A SETD1B REXO1 TBC1D16 JAK3 KMT2C BMP4 CHST15 PI4KA DIAPH2 TLN2 ABCD1 DOCK6 PLK3 HSPG2 POMGNT1 GET4 NISCH | 2.88e-05 | 1105 | 203 | 19 | 35748872 |
| Pubmed | ARHGAP24 PSMB2 POTEE ABCD3 DOCK6 ARHGEF6 SRSF4 DOCK10 CNKSR2 LBR API5 ECPAS OPHN1 NISCH DOCK7 CTSG SOS2 | 3.01e-05 | 916 | 203 | 17 | 32203420 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | NSA2 PI4KA ABCD3 DNAH3 SRSF4 SRSF6 DOCK10 FSD2 CHTF18 DOCK7 IK | 3.25e-05 | 410 | 203 | 11 | 26949251 |
| Pubmed | 3.28e-05 | 103 | 203 | 6 | 10819331 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 23991205 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 26434682 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 22136554 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 18824548 | ||
| Pubmed | Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. | 3.39e-05 | 2 | 203 | 2 | 11799243 | |
| Pubmed | Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo. | 3.39e-05 | 2 | 203 | 2 | 15276650 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 20865640 | ||
| Pubmed | A synthetic protein as efficient multitarget regulator against complement over-activation. | 3.39e-05 | 2 | 203 | 2 | 35194132 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 23243267 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 1826708 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 17114052 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 9126326 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 20685659 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24280833 | ||
| Pubmed | Myosin-7b Promotes Distal Tip Localization of the Intermicrovillar Adhesion Complex. | 3.39e-05 | 2 | 203 | 2 | 27666969 | |
| Pubmed | A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome. | 3.39e-05 | 2 | 203 | 2 | 23880784 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 20855886 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 26893383 | ||
| Pubmed | Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma. | 3.39e-05 | 2 | 203 | 2 | 23938460 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 9425230 | ||
| Pubmed | alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. | 3.39e-05 | 2 | 203 | 2 | 10523848 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 17542813 | ||
| Pubmed | CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome. | 3.39e-05 | 2 | 203 | 2 | 36755127 | |
| Pubmed | CTF18 interacts with replication protein A in response to replication stress. | 3.39e-05 | 2 | 203 | 2 | 27175616 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24014239 | ||
| Pubmed | Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces. | 3.39e-05 | 2 | 203 | 2 | 33732239 | |
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 7651409 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 15557185 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 21677636 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 11248239 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 33938457 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 16449802 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 22894814 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 28358367 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24475116 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 16566000 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 23873044 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 24008159 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 38602029 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 25659429 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 15664177 | ||
| Pubmed | 3.39e-05 | 2 | 203 | 2 | 21163921 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 3.46e-05 | 104 | 203 | 6 | 31240132 | |
| Pubmed | 3.66e-05 | 105 | 203 | 6 | 9628581 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 3.86e-05 | 106 | 203 | 6 | 31024071 | |
| Pubmed | TSC1 PI4KA ABCD3 DIAPH2 DOCK6 STXBP5 PIGS POMGNT1 SPG11 LBR NISCH TMED8 | 4.55e-05 | 504 | 203 | 12 | 34432599 | |
| Pubmed | 4.99e-05 | 68 | 203 | 5 | 14676191 | ||
| Pubmed | TSC1 GTF3C5 ABCD3 ASCC3 HSPG2 SRSF4 HDHD5 RNF213 LBR NDUFA13 PKP3 NAT10 DOCK7 | 5.85e-05 | 601 | 203 | 13 | 33658012 | |
| Pubmed | PSMB2 PI4KA CDIPT ABCD3 ABCD1 ASCC3 ABCC1 CARMIL2 PIGS LEMD2 RNF149 DOCK10 RNF213 LBR API5 ECPAS CHTF18 NISCH NAT10 | 6.05e-05 | 1168 | 203 | 19 | 19946888 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 6.40e-05 | 37 | 203 | 4 | 25798587 | |
| Pubmed | USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation. | 6.40e-05 | 37 | 203 | 4 | 32133736 | |
| Pubmed | 6.80e-05 | 14 | 203 | 3 | 2014798 | ||
| Pubmed | 6.80e-05 | 14 | 203 | 3 | 12432077 | ||
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 7.12e-05 | 38 | 203 | 4 | 19608861 | |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 7.12e-05 | 38 | 203 | 4 | 12482669 | |
| Pubmed | 7.99e-05 | 75 | 203 | 5 | 15951569 | ||
| Pubmed | Quantitative analysis of expression of mouse sialyltransferase genes by competitive PCR. | 8.47e-05 | 15 | 203 | 3 | 10381338 | |
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 8.47e-05 | 15 | 203 | 3 | 9827704 | |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 8.47e-05 | 15 | 203 | 3 | 28578927 | |
| Pubmed | PDK1 PDK3 NIPSNAP2 ATAD3C GLUD2 AGXT ABCD3 HSD3B1 NDUFB11 CPT1B NDUFA13 COX7A2L | 9.07e-05 | 542 | 203 | 12 | 14651853 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 10781834 | ||
| Pubmed | USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells. | 1.01e-04 | 3 | 203 | 2 | 22426999 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 17683942 | ||
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 35584673 | ||
| Pubmed | Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. | 1.01e-04 | 3 | 203 | 2 | 10551832 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 25205734 | ||
| Pubmed | Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. | 1.01e-04 | 3 | 203 | 2 | 18006700 | |
| Pubmed | 1.01e-04 | 3 | 203 | 2 | 34198763 | ||
| Cytoband | 9q34 | 9.87e-05 | 54 | 203 | 4 | 9q34 | |
| Cytoband | 1p34.1 | 1.22e-04 | 57 | 203 | 4 | 1p34.1 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | ARHGAP24 KIF1B PLEKHH1 PHLPP1 ARHGEF6 DOCK10 CNKSR2 PLEKHA6 SOS2 | 2.77e-05 | 206 | 137 | 9 | 682 |
| GeneFamily | ATP binding cassette subfamily D|GOLD domain containing | 1.70e-04 | 3 | 137 | 2 | 1062 | |
| GeneFamily | ATP binding cassette subfamily D | 3.39e-04 | 4 | 137 | 2 | 808 | |
| GeneFamily | O-linked N-acetylglucosaminyltransferases|Tetratricopeptide repeat domain containing | 3.39e-04 | 4 | 137 | 2 | 446 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.77e-04 | 19 | 137 | 3 | 832 | |
| GeneFamily | Sialyltransferases | 4.41e-04 | 20 | 137 | 3 | 438 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.55e-04 | 50 | 137 | 4 | 1293 | |
| GeneFamily | Ubiquitin specific peptidases | 8.54e-04 | 56 | 137 | 4 | 366 | |
| GeneFamily | Plexins | 1.98e-03 | 9 | 137 | 2 | 683 | |
| GeneFamily | Chloride voltage-gated channels | 2.46e-03 | 10 | 137 | 2 | 302 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 3.58e-03 | 12 | 137 | 2 | 737 | |
| GeneFamily | Phospholipases | 3.94e-03 | 42 | 137 | 3 | 467 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 4.21e-03 | 13 | 137 | 2 | 1146 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 4.32e-03 | 87 | 137 | 4 | 372 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-07 | 186 | 203 | 9 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.21e-06 | 185 | 203 | 8 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.80e-06 | 191 | 203 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.80e-06 | 191 | 203 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.80e-06 | 191 | 203 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-06 | 194 | 203 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.26e-06 | 195 | 203 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.26e-06 | 195 | 203 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-06 | 195 | 203 | 8 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.26e-06 | 195 | 203 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-06 | 195 | 203 | 8 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-06 | 195 | 203 | 8 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.39e-06 | 196 | 203 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.39e-06 | 196 | 203 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.52e-06 | 197 | 203 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 200 | 203 | 8 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-06 | 160 | 203 | 7 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 165 | 203 | 7 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 110 | 203 | 6 | ee45592e936d32881c0f3429c21360670e5b3ce3 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 110 | 203 | 6 | b9c8014fd2820e5ea28a7e02fd24227b99e71eb3 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 167 | 203 | 7 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 169 | 203 | 7 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 169 | 203 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 170 | 203 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 177 | 203 | 7 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 177 | 203 | 7 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 179 | 203 | 7 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.85e-05 | 179 | 203 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-05 | 181 | 203 | 7 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|World / Lineage, cell class and subclass | 1.99e-05 | 181 | 203 | 7 | 0d096d7d557fd2e71b35e41816e11d7e83cd9210 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.06e-05 | 182 | 203 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 185 | 203 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.29e-05 | 185 | 203 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.29e-05 | 185 | 203 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 187 | 203 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|lymphoid / Lineage, cell class and subclass | 2.45e-05 | 187 | 203 | 7 | 99dfa50f6325b0d66d23ee8dcaa6437e7161628a | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.62e-05 | 189 | 203 | 7 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.62e-05 | 189 | 203 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-05 | 189 | 203 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.62e-05 | 189 | 203 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.62e-05 | 189 | 203 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-05 | 191 | 203 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-05 | 191 | 203 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.90e-05 | 192 | 203 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.90e-05 | 192 | 203 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.00e-05 | 193 | 203 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 193 | 203 | 7 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.10e-05 | 194 | 203 | 7 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.10e-05 | 194 | 203 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 132 | 203 | 6 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-05 | 195 | 203 | 7 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 195 | 203 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.20e-05 | 195 | 203 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 195 | 203 | 7 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 195 | 203 | 7 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 195 | 203 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 196 | 203 | 7 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.31e-05 | 196 | 203 | 7 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-05 | 197 | 203 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.42e-05 | 197 | 203 | 7 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.42e-05 | 197 | 203 | 7 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 197 | 203 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.42e-05 | 197 | 203 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.42e-05 | 197 | 203 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.53e-05 | 198 | 203 | 7 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.53e-05 | 198 | 203 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.76e-05 | 200 | 203 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-05 | 200 | 203 | 7 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.76e-05 | 200 | 203 | 7 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-05 | 200 | 203 | 7 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | mLN-Dendritic_cell-pDC|Dendritic_cell / Region, Cell class and subclass | 3.76e-05 | 200 | 203 | 7 | 10ae1ac8a98346320a92e855aebb3a7109f0ab9b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.76e-05 | 200 | 203 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.76e-05 | 200 | 203 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.76e-05 | 200 | 203 | 7 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-05 | 200 | 203 | 7 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.21e-05 | 144 | 203 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 145 | 203 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.56e-05 | 154 | 203 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.56e-05 | 154 | 203 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.12e-05 | 156 | 203 | 6 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.65e-05 | 161 | 203 | 6 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.99e-05 | 162 | 203 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.99e-05 | 162 | 203 | 6 | 985adca17b0c99563feef7910f3da5df31e636b6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 164 | 203 | 6 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 55 | 203 | 4 | 6575ee5274f1044e17f4a5204375acc82ef16182 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 55 | 203 | 4 | 21a72cc6f12889509dbfaa9929be48d00f5f6345 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-04 | 168 | 203 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 169 | 203 | 6 | 780fb0050852626062a729dd1b82b0cf61e7e9ca | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-04 | 169 | 203 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.30e-04 | 170 | 203 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 170 | 203 | 6 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 170 | 203 | 6 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-04 | 171 | 203 | 6 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 172 | 203 | 6 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 1.39e-04 | 172 | 203 | 6 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 172 | 203 | 6 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 172 | 203 | 6 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 173 | 203 | 6 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 173 | 203 | 6 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 173 | 203 | 6 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| Drug | 3-nitrocoumarin | 1.12e-06 | 10 | 198 | 4 | CID002799766 | |
| Drug | AC1Q6T8I | 5.65e-06 | 30 | 198 | 5 | CID000000343 | |
| Drug | Methacholine chloride [62-51-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 8.87e-06 | 196 | 198 | 10 | 3452_DN | |
| Drug | exemestane; Up 200; 0.01uM; MCF7; HG-U133A | SETD1B PDK3 ETV1 DUS2 ST3GAL5 ABCD1 NDUFB11 DNAH3 SPG11 CPT1B | 1.01e-05 | 199 | 198 | 10 | 165_UP |
| Drug | C10A | 1.27e-05 | 6 | 198 | 3 | CID000041624 | |
| Drug | SKF83742 | 1.27e-05 | 6 | 198 | 3 | CID000130828 | |
| Drug | (?-Fluprostenol | 1.50e-05 | 61 | 198 | 6 | CID000003391 | |
| Drug | norathyriol | 1.64e-05 | 37 | 198 | 5 | CID005281656 | |
| Drug | sapintoxin A | 1.94e-05 | 19 | 198 | 4 | CID000108085 | |
| Drug | carbimazole | 2.57e-05 | 67 | 198 | 6 | CID000031072 | |
| Disease | phosphatidylinositol measurement | 3.34e-06 | 95 | 195 | 7 | EFO_0010230 | |
| Disease | complement C1s subcomponent measurement | 5.60e-06 | 6 | 195 | 3 | EFO_0008091 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.48e-05 | 23 | 195 | 4 | OBA_2045158 | |
| Disease | West Syndrome | 1.77e-05 | 24 | 195 | 4 | C0037769 | |
| Disease | mean arterial pressure | ARHGAP24 DCDC1 RGS19 REXO1 RYK CLCN6 AGXT FGR STXBP5 DOCK10 PKD2L1 RNF213 UTP25 | 3.06e-05 | 499 | 195 | 13 | EFO_0006340 |
| Disease | IGA glomerulonephritis | 4.13e-05 | 58 | 195 | 5 | EFO_0004194 | |
| Disease | cardiovascular disease | DCDC1 TBC1D7 REXO1 RYK CLCN6 ST3GAL5 AGXT PLCB1 PKD2L1 DOCK7 COX7A2L SOS2 | 5.75e-05 | 457 | 195 | 12 | EFO_0000319 |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 7.74e-05 | 13 | 195 | 3 | OBA_2045159 | |
| Disease | lymphocyte count | UBAP2 RGS19 KIF1B TBC1D7 ETV1 NIPSNAP2 RRM1 TBC1D16 ST3GAL5 PLCB1 PHLPP1 TADA2A ABCD1 HORMAD2 ABCC1 CARMIL2 DOCK10 PKD2L1 PLEKHA6 PKP3 SLC22A5 PHTF1 SP140 | 1.10e-04 | 1464 | 195 | 23 | EFO_0004587 |
| Disease | anaphase-promoting complex subunit 7 measurement | 1.30e-04 | 3 | 195 | 2 | EFO_0801381 | |
| Disease | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 | 1.30e-04 | 3 | 195 | 2 | C2749604 | |
| Disease | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 | 1.30e-04 | 3 | 195 | 2 | 235400 | |
| Disease | calnexin measurement | 1.30e-04 | 3 | 195 | 2 | EFO_0801444 | |
| Disease | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 1.30e-04 | 3 | 195 | 2 | cv:C2749604 | |
| Disease | angiopoietin-related protein 3 measurement | 1.30e-04 | 3 | 195 | 2 | EFO_0020148 | |
| Disease | hypoglycemia (biomarker_via_orthology) | 1.30e-04 | 3 | 195 | 2 | DOID:9993 (biomarker_via_orthology) | |
| Disease | complement factor H-related protein 4A measurement | 1.30e-04 | 3 | 195 | 2 | EFO_0600057 | |
| Disease | tetradecenoylcarnitine meaasurement | 1.30e-04 | 3 | 195 | 2 | EFO_0021809 | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 1.30e-04 | 3 | 195 | 2 | EFO_0801683 | |
| Disease | carnitine measurement | 1.51e-04 | 76 | 195 | 5 | EFO_0010469 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 2.16e-04 | 18 | 195 | 3 | OBA_2045155 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 2.58e-04 | 4 | 195 | 2 | EFO_0803292 | |
| Disease | protein wnt-7a measurement | 2.58e-04 | 4 | 195 | 2 | EFO_0020689 | |
| Disease | Adams-Oliver syndrome | 2.58e-04 | 4 | 195 | 2 | cv:C0265268 | |
| Disease | kallikrein-5 measurement | 2.58e-04 | 4 | 195 | 2 | EFO_0020515 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 2.98e-04 | 20 | 195 | 3 | OBA_2045071 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 3.46e-04 | 21 | 195 | 3 | OBA_2045156 | |
| Disease | interleukin-17 receptor A measurement | 4.29e-04 | 5 | 195 | 2 | EFO_0801718 | |
| Disease | phosphatidylcholine measurement | 6.35e-04 | 284 | 195 | 8 | EFO_0010226 | |
| Disease | Membranoproliferative Glomerulonephritis, Type II | 6.40e-04 | 6 | 195 | 2 | C0268743 | |
| Disease | Congenital defect of skull and scalp | 6.40e-04 | 6 | 195 | 2 | C2931779 | |
| Disease | level of Phosphatidylcholine (18:2_18:2) in blood serum | 6.40e-04 | 6 | 195 | 2 | OBA_2045106 | |
| Disease | Adams Oliver syndrome | 6.40e-04 | 6 | 195 | 2 | C0265268 | |
| Disease | protachykinin-1 measurement | 6.40e-04 | 6 | 195 | 2 | EFO_0801934 | |
| Disease | nischarin measurement | 6.40e-04 | 6 | 195 | 2 | EFO_0801841 | |
| Disease | Adams-Oliver syndrome 1 | 6.40e-04 | 6 | 195 | 2 | C4551482 | |
| Disease | angiopoietin-1 receptor, soluble measurement | 6.40e-04 | 6 | 195 | 2 | EFO_0008023 | |
| Disease | riboflavin kinase measurement | 6.40e-04 | 6 | 195 | 2 | EFO_0802016 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 6.40e-04 | 6 | 195 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | GALNS ETV1 KMT2C BMP4 NPAP1 ABCD3 ABCC1 DNAH3 SRSF6 CAPN6 CNKSR2 SLC44A4 PDGFD | 8.46e-04 | 702 | 195 | 13 | C0009402 |
| Disease | adrenoleukodystrophy (implicated_via_orthology) | 8.93e-04 | 7 | 195 | 2 | DOID:10588 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in very large HDL percentage | 1.11e-03 | 31 | 195 | 3 | EFO_0022243 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 1.19e-03 | 8 | 195 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Hyperoxaluria | 1.19e-03 | 8 | 195 | 2 | C0020500 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 1.19e-03 | 8 | 195 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | kidney disease | 1.19e-03 | 8 | 195 | 2 | EFO_0003086 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.28e-03 | 121 | 195 | 5 | EFO_0004612, EFO_0005271 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 1.46e-03 | 34 | 195 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | Atypical hemolytic-uremic syndrome | 1.52e-03 | 9 | 195 | 2 | cv:C2931788 | |
| Disease | bile salt-activated lipase measurement | 1.52e-03 | 9 | 195 | 2 | EFO_0801425 | |
| Disease | C3 glomerulopathy | 1.52e-03 | 9 | 195 | 2 | C4087273 | |
| Disease | Hemolytic-uremic syndrome | 1.52e-03 | 9 | 195 | 2 | cv:C0019061 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 1.52e-03 | 9 | 195 | 2 | EFO_0801766 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 1.52e-03 | 9 | 195 | 2 | EFO_0800439 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement | 1.52e-03 | 9 | 195 | 2 | EFO_0800412 | |
| Disease | docosahexaenoic acid measurement | 1.59e-03 | 127 | 195 | 5 | EFO_0007761 | |
| Disease | total lipids in small HDL measurement | 1.59e-03 | 35 | 195 | 3 | EFO_0022311 | |
| Disease | free cholesterol in small HDL measurement | 1.59e-03 | 35 | 195 | 3 | EFO_0022270 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 1.89e-03 | 10 | 195 | 2 | C2931788 | |
| Disease | Secreted frizzled-related protein 3 measurement | 1.89e-03 | 10 | 195 | 2 | EFO_0008277 | |
| Disease | phospholipids in small HDL measurement | 2.02e-03 | 38 | 195 | 3 | EFO_0022296 | |
| Disease | pneumococcal bacteremia | 2.30e-03 | 11 | 195 | 2 | EFO_1001925 | |
| Disease | interleukin 17 receptor A measurement | 2.30e-03 | 11 | 195 | 2 | EFO_0008175 | |
| Disease | hemopexin measurement | 2.30e-03 | 11 | 195 | 2 | EFO_0008149 | |
| Disease | phospholipid measurement | 2.43e-03 | 140 | 195 | 5 | EFO_0004639 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 2.47e-03 | 352 | 195 | 8 | EFO_0007014 | |
| Disease | cataract | 2.51e-03 | 141 | 195 | 5 | MONDO_0005129 | |
| Disease | clinical treatment | 2.52e-03 | 41 | 195 | 3 | EFO_0007056 | |
| Disease | fatty acid measurement | 2.58e-03 | 436 | 195 | 9 | EFO_0005110 | |
| Disease | protein CEI measurement | 2.75e-03 | 12 | 195 | 2 | EFO_0801936 | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 3.23e-03 | 13 | 195 | 2 | EFO_0010592 | |
| Disease | homostachydrine measurement | 3.23e-03 | 13 | 195 | 2 | EFO_0021164 | |
| Disease | cerotoylcarnitine (C26) measurement | 3.23e-03 | 13 | 195 | 2 | EFO_0800542 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 3.23e-03 | 13 | 195 | 2 | EFO_0800413 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.56e-03 | 153 | 195 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 3.75e-03 | 14 | 195 | 2 | EFO_0022085 | |
| Disease | wet macular degeneration | 3.75e-03 | 14 | 195 | 2 | EFO_0004683 | |
| Disease | total lipids in lipoprotein particles measurement | 3.95e-03 | 48 | 195 | 3 | EFO_0022309 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.17e-03 | 303 | 195 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.19e-03 | 49 | 195 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 4 measurement | 4.19e-03 | 49 | 195 | 3 | EFO_0600091 | |
| Disease | interferon gamma measurement | 4.69e-03 | 51 | 195 | 3 | EFO_0008165 | |
| Disease | testosterone measurement | ZHX3 DCDC1 PSMB2 REXO1 RYK ST3GAL5 PLCB1 FAM47E ARHGEF6 NR1H4 HORMAD2 UBQLN2 ANK3 OPHN1 NISCH CEP70 SOS2 | 4.89e-03 | 1275 | 195 | 17 | EFO_0004908 |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 4.91e-03 | 16 | 195 | 2 | EFO_0800184 | |
| Disease | Spondyloepiphyseal Dysplasia | 4.91e-03 | 16 | 195 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 4.91e-03 | 16 | 195 | 2 | C0036391 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.91e-03 | 16 | 195 | 2 | C3541456 | |
| Disease | anthranilic acid measurement | 4.91e-03 | 16 | 195 | 2 | EFO_0010460 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.91e-03 | 16 | 195 | 2 | C4551479 | |
| Disease | Melnick-Needles Syndrome | 4.91e-03 | 16 | 195 | 2 | C0025237 | |
| Disease | lipoprotein measurement | 5.26e-03 | 105 | 195 | 4 | EFO_0004732 | |
| Disease | complement factor H-related protein 3 measurement | 5.41e-03 | 169 | 195 | 5 | EFO_0600056 | |
| Disease | Amyotrophic lateral sclerosis | 5.54e-03 | 17 | 195 | 2 | cv:C0002736 | |
| Disease | Van Buchem disease | 5.54e-03 | 17 | 195 | 2 | C0432272 | |
| Disease | protein C measurement | 5.54e-03 | 17 | 195 | 2 | EFO_0004633 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 5.70e-03 | 243 | 195 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | ecosanoids measurement | 5.79e-03 | 55 | 195 | 3 | EFO_0020044 | |
| Disease | phospholipids in medium HDL measurement | 5.79e-03 | 55 | 195 | 3 | EFO_0022295 | |
| Disease | von Willebrand factor measurement | 6.09e-03 | 56 | 195 | 3 | EFO_0004629 | |
| Disease | Age-related macular degeneration | 6.20e-03 | 18 | 195 | 2 | cv:C0242383 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YRYLNTRKLDMPETR | 111 | A0A1B0GUX0 | |
| IEERYGKYNISDPLM | 41 | Q9P2B4 | |
| MLAYSLTYRQERTPD | 796 | Q8WVB6 | |
| FSLLPRMRYGLFYNT | 316 | Q5NDL2 | |
| RMRYGLFYNTPLISG | 321 | Q5NDL2 | |
| RYPIRSGMVSAYNLN | 66 | Q5FYA8 | |
| RKAAQRYLMDYLNPL | 1446 | Q96N23 | |
| QDLTTRYLPRGMCIY | 786 | A0A096LP49 | |
| RPSAALGYKERMSYI | 601 | Q15052 | |
| NETPNRVMLDYYREG | 546 | Q8TD16 | |
| RPMYIYGEGSRFLSA | 186 | P14060 | |
| PRYTRDSKAYSMILL | 1166 | Q6F5E8 | |
| RKMPTDYIRNGVLYV | 476 | Q6IC98 | |
| MYRLSYQVQGPRPVL | 371 | Q9UK96 | |
| MPTVEELYRNYGILA | 1 | Q9BZZ5 | |
| ILTRNGESPIYMYLQ | 306 | A6NGH8 | |
| SRQMSKYPSGERVRY | 1061 | P08603 | |
| MASLPYEYRLQHRTV | 2161 | Q96M86 | |
| AKNLLPRRTMTLTYY | 1446 | Q96PN6 | |
| KMIDLSGNPVLRIYY | 121 | O14735 | |
| LGSYRMPYEDIRNVI | 721 | O60879 | |
| SAVIPDYMRDLYRLQ | 76 | P12644 | |
| LYKSGQNMEEYRPRT | 1156 | O60312 | |
| QDYPLANMYAITRVL | 736 | Q709F0 | |
| AYYLRPKSEMLRSNR | 171 | Q9ULI1 | |
| MPQNEYIELHRKRYG | 1 | O95478 | |
| IYELRSYQLRPGTMI | 186 | O75323 | |
| YNVRYELARGMLEPV | 616 | P98160 | |
| RDPASRGDRYMLVTY | 41 | Q5JSJ4 | |
| YGPGRQSLRLVMEYL | 891 | P52333 | |
| FYLRNLSEPVMTYRL | 451 | O60890 | |
| LRSLGEKRQLYYAME | 381 | Q8IVL6 | |
| TRVEPPQYMIDLYNR | 81 | Q9UK05 | |
| SVYLYMRSLKAPRND | 341 | Q14739 | |
| YELRRMPAETLYQGE | 96 | Q96RI1 | |
| RKIDRLFNYMYSTAP | 326 | Q15118 | |
| YIPQRPYMSVGSLRD | 541 | P33897 | |
| LTYRIINYTPDMARA | 111 | Q9H306 | |
| TIRMNLNLPARYFYD | 326 | M0R2J8 | |
| AFLYDIYLRMTGRSP | 361 | Q8WVX9 | |
| NYTFRYGRNPLMELP | 4686 | Q8NEZ4 | |
| RKLDMGGYYITTRVQ | 201 | P09769 | |
| QDMERYPYVGILHVR | 431 | Q8NC56 | |
| KRYLRMAVLTLYTDP | 96 | Q8N7B1 | |
| LNRVTPYGEKIYMTL | 1371 | O60333 | |
| TDLAYYLVRKGMPFR | 371 | P04424 | |
| DRDGLYKMNRLYLTP | 236 | Q2M2W7 | |
| RRASLPGRDDNSYMY | 46 | Q9Y6H6 | |
| QVMGRKYIRLYSPQE | 331 | Q8N371 | |
| METPSIKGLYYRRVR | 31 | Q8TDN1 | |
| LPNMYIGTIEYDPRT | 161 | Q13585 | |
| QMRFRAPLLYEQYIG | 176 | Q96F63 | |
| LLMPYGYVLNESQSR | 181 | Q5VYK3 | |
| YYLQAQKGMAVTPRE | 311 | Q9NVF9 | |
| RNGYYRADLDPLDMP | 306 | P29323 | |
| YYQILSGRKPELQDM | 331 | A7E2Y1 | |
| LENMYLDTPRYRGRS | 236 | Q9GZP0 | |
| GIPFLDYRTYTMRVL | 1311 | Q9HCM2 | |
| GEPLYMLFRAIQYQV | 1471 | Q9ULL4 | |
| RPAMNYDKLSRSLRY | 381 | P50549 | |
| YKRNLPRRGLSGYSM | 21 | Q9P0J0 | |
| VYLPMSKRQEYLRSS | 81 | P57055 | |
| VRGYLAVRPYMDAVV | 2021 | P42356 | |
| LKTRAGMPFRVYHYQ | 336 | Q9Y5X9 | |
| NYPLELYERVRMGPS | 306 | P05129 | |
| DMNIYELIRGRRYPL | 86 | Q9UQ07 | |
| NYRIAGARLMRSNYP | 211 | Q8N319 | |
| AMAYDRYVAIRNPLL | 121 | Q8NGR4 | |
| RYVAIRNPLLYTTAM | 126 | Q8NGR4 | |
| GLLFASRYPIMDVAY | 406 | Q9NY59 | |
| PRGPRELEFYNMVYA | 81 | Q8NFU5 | |
| GSRALQLLQMYYEGR | 641 | Q9H0A0 | |
| SDREYPRLGQMIVDY | 171 | Q9Y2A7 | |
| YEEMSLYHQPANRKR | 466 | Q8N3R9 | |
| PDYLMKILTERGYRF | 886 | Q6S8J3 | |
| RIYPKGTRVDSSNYM | 646 | Q01970 | |
| SAYGGRKLMYLQELP | 91 | Q9NPH6 | |
| PVDYREYGRRLVMSI | 596 | P27694 | |
| VRYEKRYGNRLAPML | 141 | Q8N264 | |
| TLLQGRLMDRPIFYY | 371 | P34059 | |
| LQQMLERRYTPYPNL | 706 | P51797 | |
| PYEITYRPRTMNLEN | 4686 | Q4G0P3 | |
| RKQAQIASLYMPLYG | 1196 | Q96BY6 | |
| LMYRIARGYQGSPDL | 1581 | Q96HP0 | |
| DLMYRIAKGYQTSPD | 1671 | Q96N67 | |
| MYRGIYTVPNLLSEQ | 11 | Q86V35 | |
| YRNLDASPTYKGLLM | 246 | Q8NHQ1 | |
| SLNGVYPRMNEVYTR | 481 | Q8NHQ1 | |
| YYLTNGIRKDMIAPE | 236 | Q8TD57 | |
| LGAPNYRKLMRRYSI | 1416 | Q5JV73 | |
| RYYPQLMSLVGNVLR | 111 | Q3B7J2 | |
| RKRYSYLTEPGMIER | 1466 | Q12955 | |
| RMYLNEYVLKPATEG | 311 | Q5T2N8 | |
| IPFTARYRGNYRDIM | 241 | Q6ZMT9 | |
| YLKRGLPDQMLYRTT | 76 | O14548 | |
| GNIYLADYRIMEGIP | 311 | O75342 | |
| ESRPHSRPYMAYLQI | 26 | P08311 | |
| RNNGSLDRPYYMSKS | 676 | Q53GD3 | |
| GLRPLEEVMQKYIRY | 256 | Q9NX74 | |
| RQMSKYPSGERVRYE | 161 | Q03591 | |
| RDRVLMYGQPYRVTL | 96 | Q96G97 | |
| DLRTYRRMGRPDNYI | 406 | Q9Y6Q1 | |
| YYLVDTPVQPMTRRL | 1621 | D6RIA3 | |
| GYNLMKPFLSEDTRR | 201 | Q9UDX4 | |
| YLPRRYSMATALFLG | 396 | O76082 | |
| MAAYLKDGYRIAQPI | 551 | P34925 | |
| MYRYLAKALLPSRAG | 1 | P49448 | |
| LGSTFVAYLPDYRMK | 101 | Q9NX14 | |
| YIYLRGRSPLMVNSN | 241 | Q92523 | |
| DLQDPRYSTELGMYQ | 166 | Q9UGB7 | |
| YLSRHDRGYIQMTPL | 56 | P33527 | |
| DSQILYYAMLGVNPR | 271 | Q96S52 | |
| YMRVRGHLYPTEAAL | 261 | Q8N8U3 | |
| SRGYRTPRFLENMYI | 361 | Q6ZV65 | |
| LPYKRSLRNLMADYL | 1171 | Q8N1G1 | |
| MNSYRDLFYPERTAL | 286 | Q68CQ4 | |
| SQRKVRMNSYPYLAD | 196 | Q9Y580 | |
| RVYSLMENNSYPRFL | 176 | P41220 | |
| QLQIYTLMHRDSYPR | 181 | P49795 | |
| GQEDYDRLRPLSYPM | 66 | P17081 | |
| YLEYIQRNLPEGVAM | 156 | P82664 | |
| MPRVYIGRLSYQARE | 1 | Q08170 | |
| TPLYMDRQGIDILYS | 191 | P21549 | |
| PENYLHGRLTKRYMQ | 206 | Q8IWZ5 | |
| PVMYIHRQSAYLLGR | 271 | Q8TAD8 | |
| LQGSMDRIYKQYSPR | 381 | Q07890 | |
| RIYPKGGRVDSSNYM | 621 | Q15147 | |
| EDYMIVYLNGATPRR | 2956 | Q8WUY3 | |
| MVRLVPGAYLEYKSA | 386 | O75478 | |
| LRRDPMYNEYLDRIG | 266 | Q7L5D6 | |
| NSREYMSPDIALLYL | 131 | Q7RTY7 | |
| VIAGNRPNYLYRMLR | 306 | Q8WZA1 | |
| RSYIIYVRALNMGGP | 536 | A1L4K1 | |
| RKLYAVGDNPMSDVY | 306 | Q9BXW7 | |
| LYANLRGLTMYQGER | 971 | Q9BQS7 | |
| RVYLDNLPSASMYER | 71 | Q96BP3 | |
| GPRFMTSEYNSKYLR | 171 | Q7Z5V6 | |
| LYKMRNGYELSPTAA | 66 | P49721 | |
| RITYPEGAMQRPEQY | 206 | Q11203 | |
| GRAMPSEYTYVKLRS | 26 | Q9UNP4 | |
| EGTRALYRGYLPNML | 236 | Q8N5S1 | |
| MRFYELLVTGRYTPQ | 186 | Q9UPS6 | |
| MPRVYIGRLSYNVRE | 1 | Q13247 | |
| EVYLRMYQLESGKLP | 106 | Q9P0N9 | |
| DVYYLPLTNMRIART | 981 | Q5T5C0 | |
| VSRKEEYIRFYMGLP | 841 | Q9NZP6 | |
| GVPLRKIDRLFNYMY | 291 | Q15120 | |
| KIDRLFNYMYSTAPR | 296 | Q15120 | |
| ERMLPDYYNTRVVGA | 621 | Q66K14 | |
| ERGKLFYVPQRPYMT | 501 | P28288 | |
| RPYMTLGTLRDQVIY | 511 | P28288 | |
| RRLIMNPSYYNLGDV | 1761 | Q8N3C0 | |
| YRRVNPMHGVEYILD | 526 | Q70JA7 | |
| YMLVRYEDVARGPLQ | 366 | Q7LGC8 | |
| NAMPVRLQVGLYAVY | 446 | Q7LFX5 | |
| EPRALQYEQTLMYGR | 11 | P51788 | |
| YGPYPLAESERMQVL | 821 | Q8WXI2 | |
| AYGTRRHLYDPKMQT | 181 | Q15417 | |
| LRNLSYRLYDEMPPS | 531 | Q9Y446 | |
| YRLYDEMPPSALQRL | 536 | Q9Y446 | |
| SGYKVRDLRTYIMPA | 246 | P11086 | |
| RLLTGIGRYNEMTYI | 2161 | Q96JI7 | |
| LRQDHPGQMDRYLVY | 4316 | Q63HN8 | |
| QPQLGILRYFASYME | 526 | Q9H4B4 | |
| IYADPAAYVMRRSIS | 491 | Q9Y2H5 | |
| VLYNEERYGNITLPM | 136 | Q8NC42 | |
| YRTLLQLTRMYPGLQ | 166 | Q9H4F1 | |
| PIYGYDELQMLQSRL | 821 | Q5T6F2 | |
| DRGPMLVNTLVDYYL | 36 | Q92574 | |
| PPQRTLYRDVMLETY | 46 | P17025 | |
| FTIARYMELRGYPLR | 1001 | Q9P217 | |
| PSQRALYRDVMLENY | 31 | Q06732 | |
| GKQYMLRRPALEDYV | 206 | Q9BVS5 | |
| DQRVSMPYASKGLYL | 106 | P04275 | |
| RLYGLTMNPLIYNIT | 721 | Q9UMS5 | |
| GLVPMLRVYNNTARY | 271 | P23921 | |
| MYYLRTRPAANPIQF | 736 | P23921 | |
| RQYRPREYLAGDVMS | 61 | Q9H2B4 | |
| FRQLKSSPDMLYQYL | 556 | Q9H6T3 | |
| GLIYRPRDFASYMLG | 701 | Q9NXL6 | |
| ESMRRILLNYAVYNP | 511 | Q8TBP0 | |
| LDRVLMGYQTYPQAL | 1416 | Q9Y2I1 | |
| AYMLIYRLKDPARNA | 556 | Q96K76 | |
| NRESYMVPFIPLYRN | 421 | P14679 | |
| GMYRVGLPSRKTLYQ | 126 | Q3KQV9 | |
| TYLRKARMATFYGPL | 2036 | P08922 | |
| QRNRIDTLMYLLAYP | 701 | Q9NW08 | |
| YERNELFLPGRMAYV | 226 | Q13123 | |
| MYRYRQDPGKGLRLI | 51 | A0A0A0MS04 | |
| RIYPKGTRVDSSNYM | 596 | Q9NQ66 | |
| SFIYYENMLLGVPRL | 186 | Q9P0L9 | |
| VLRQGQIMYYKSPSD | 601 | Q9ULM0 | |
| AGLMEADIYQTPRYL | 16 | P0DTU4 | |
| PSQRNLYRDVMLETY | 46 | Q6P3V2 | |
| PSQRALYRDVMLENY | 31 | Q06730 | |
| QDPGMGLRLIYYSAA | 56 | A0A0A6YYG3 | |
| AGRTLDYYMLRNGDI | 66 | Q9Y4G6 | |
| PVPNYLSYMDVSRNR | 891 | O60346 | |
| SRINLMAYPDLNEIY | 116 | Q13342 | |
| AGLMEADIYQTPRYL | 16 | A0A075B6N4 | |
| REGALPPYRQMFYQL | 396 | Q9Y5Q8 | |
| IPGGYNALRRMYTDI | 261 | Q9UHD9 | |
| VIAPGNRELLQDYYM | 841 | Q9H4I2 | |
| MYRLSRYVTKPNSDD | 636 | P51784 | |
| PVRYGLRLNMDEKYT | 731 | P35125 | |
| LLNTLRELNPMYEGY | 181 | O94782 | |
| RSSLRGRYGEVMPVY | 266 | Q6PL24 | |
| LARNLNRMYKLYPSE | 156 | A6NNM8 | |
| YYGIPMRLGSRAEIT | 431 | Q6ZT21 | |
| ATMIYYAERIGARPS | 396 | Q03721 | |
| MLSKDPRVSYQYRQD | 396 | Q9NR99 | |
| FVAILRYMGDYPSRQ | 1671 | Q6PIF6 | |
| YMLSKSLYPDRVTQN | 1371 | Q13224 |